about
The involvement of the cerebellum in amyotrophic lateral sclerosis.Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosisTics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms.Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imaging.Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis.Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?Calcium-dependent protein folding in amyotrophic lateral sclerosis.The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis.Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature.The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis.Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.[Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network].Expression pattern of peptidylarginine deiminase in rat and human Schwann cells.Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons.Transcranial brainstem sonography as a diagnostic tool for amyotrophic lateral sclerosis.Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis.Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.Sigma 1 receptor activation modifies intracellular calcium exchange in the G93AhSOD1 ALS model.Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease.Disease Specific Aspects of Malnutrition in Neurogeriatric Patients.Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosisMuskelultraschall – ein sinnvolles Werkzeug bei der Diagnosestellung der amyotrophen LateralskleroseOrnithine transcarbamylase (OTC) deficiency based on a hemizygous p.R277W mutation causing life-threatening hyperammonemic crisis during treatment for Hodgkin’s lymphomaComparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson's diseaseReaction to Endoplasmic Reticulum Stress ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With AgingPlasma VCAM1 levels correlate with disease severity in Parkinson's diseaseCause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatmentSpecially designed palate prosthesis reconstitutes speech in amyotrophic lateral sclerosisEndoplasmic reticulum stress is accompanied by activation of NF-κB in amyotrophic lateral sclerosisSicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of LifeOutcome of Older Patients with Acute Neuropsychological Symptoms Not Fulfilling Criteria of DeliriumDisease progression impacts health-related quality of life in amyotrophic lateral sclerosisCerebral patterns of neuropsychological disturbances in hepatitis C patientsClusters of non-adherence to medication in neurological patientsCognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosisAdherence to medication in neurogeriatric patients: an observational cross-sectional studyData on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cellsDysphagia from a neurogeriatric point of view : Pathogenesis, diagnosis and management
P50
Q30657480-EF67F1C9-F75A-4450-B8E3-FF9FA73A9763Q34061536-46A69B31-2FB6-4518-964A-DF6124736BAAQ35084397-7F0C633F-BC5E-460A-860B-44E445FE91FFQ35673619-814CD635-14DF-40A4-8B10-1A3A9FDD162AQ35673939-214421E7-7725-4B52-B929-936C3E6CEAABQ37235901-B75C0C5D-6DEA-4099-AA18-5BD3F05B2F2CQ38114239-7ED84601-95D9-42A4-84F9-0E77A4FC6618Q38218666-9D928823-34D0-43E1-BFC2-09DD669A3950Q38544555-D4DEC0C5-AF83-4847-8B64-CDE7E6C9857FQ39385508-D8FEA57D-2568-4443-AD6C-721360B2DA4DQ41392222-C299E413-0D82-4B89-B88E-CC4B55DF2C48Q41537349-A60A64F3-50EB-4B31-8D5D-5A57740586C6Q46941802-D5B8F8F8-CA35-46A2-B01D-DE5543F690EDQ48017606-029B3A66-661C-43F9-A4A9-D7C99E07554BQ48085316-30DAF427-B5D9-44D9-93F1-B5670D875B8DQ51004875-ECD40B81-7914-49AA-949F-17D418FB559FQ51619809-5F1F55A7-7677-4426-B2B8-EAFEFEBEB1E0Q51758743-243B2CD2-E918-4E01-ACFD-6280A32D08B9Q53714594-3ECD4234-3FBF-4FE3-B5A2-FAE9A400F62EQ55054279-75DA8751-C273-4421-9A11-D62643F9D720Q55128164-FE486107-F664-4FC3-A230-FAA0E2566674Q57727026-8518C32A-95C0-48AE-9C9C-130759A30593Q57727083-79306E02-C10E-4D85-A0F5-ADD4F77B2D88Q58023823-2A3844F3-B8C0-4900-B95E-83D1AAF2885DQ61446536-2ED50245-6CD5-463B-93F9-EF6066F90C29Q61809056-FAC39D59-B633-4B07-BA70-634CBE979CDAQ64062302-D1B42B18-4997-42E8-ADE8-2C72D30126ACQ64120522-D59197DA-9EF4-4C65-AA1F-357296B65DD0Q84747302-4803B304-24DE-45CE-BB7C-7D494ADE6313Q87515921-6B5E2161-9AC4-4DCD-B780-42D0910E36D8Q89910644-8ED1FB70-5DA2-40FE-AB52-4DB576BE31F4Q90552289-5DB306E1-E7C9-4CFC-AED6-3D854A2741E9Q90826603-D1883614-34E0-43C7-A653-108F9E555844Q90898601-66AF82F8-0CD3-45A4-B21B-74DA506964DEQ91647883-C8B4C7CF-FE6E-4514-9893-5D1602191DC1Q91981221-62C8E47C-B8C1-4ABE-891B-1862D0C1D483Q92260300-62F4339A-0C07-4BD9-92F5-30DA33F2ADF9Q92357611-41245D87-8DB1-4717-971F-CBB45FF193E2Q92357780-2EC1C084-39B1-4B01-9A46-EDB48D21F550Q92363738-1A95C9BA-3BC6-4A84-BD2C-683B29F56D34
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tino Prell
@ast
Tino Prell
@en
Tino Prell
@es
Tino Prell
@nl
type
label
Tino Prell
@ast
Tino Prell
@en
Tino Prell
@es
Tino Prell
@nl
prefLabel
Tino Prell
@ast
Tino Prell
@en
Tino Prell
@es
Tino Prell
@nl
P214
P106
P1153
57203859188
P214
P2798
P31
P496
0000-0002-6423-3108
P7859
viaf-81572704